RPL19 and colorectal carcinoma: Western blot analyses were employed to verify the results of the MRM analysis in another CRC sample set, with the exception of protein RPL19 due to the lack of a detectable antibody and protein RPS18, which failed to reach the limit of detection in CRC samples.